Produktname:2-(2-bromo-5-methoxyphenyl)-1,3-dioxolane
IUPAC Name:2-(2-bromo-5-methoxyphenyl)-1,3-dioxolane
- CAS：98015-07-7
- Molekulare Formel：C10H11BrO3
- Reinheit：95%
- Katalognummer：CM279844
- Molekulargewicht：259.1
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:98015-07-7
- Molekulare Formel:C10H11BrO3
- Schmelzpunkt:-
- SMILES-Code:COC1=CC=C(Br)C(C2OCCO2)=C1
- Dichte:
- Katalognummer:CM279844
- Molekulargewicht:259.1
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Category Infos
- Dioxolanes
- Dioxolane is a heterocyclic acetal with the formula (CH2)2O2CH2. It is related to tetrahydrofuran by exchanging an oxygen for the CH2 group. The isomer 1,2-dioxolane (in which the two oxygen centers are adjacent) is a peroxide. 1,3-Dioxolane is used as solvent and comonomer in polyacetal. The dioxolane-type and their hydrogenolysis can provide very valuable partially protected building blocks either for oligosaccharide syntheses or sugar transformations.
Column Infos
- Sparsentan
- CSL Vifor and Travere Therapeutics announce European Commission approves FILSPARI(sparsentan) for the treatment of IgA Nephropathy (IgAN). First non-immunosuppressive therapy for the treatment of IgAN approved in Europe.
Sparsentan is a novel, non-immunosuppressive, single-molecule, dual endothelin angiotensin receptor antagonist with high selectivity for the endothelin A receptor (ETAR) and the angiotensin II subtype 1 receptor (AT1R). Pre-clinical data have shown that blockade of both endothelin type A and angiotensin II type 1 pathways in forms of rare chronic kidney disease, protects podocytes, prevents glomerulosclerosis and mesangial cell proliferation, and reduces proteinuria.
Suche 
+86 21 5895 0110 
